Gene therapy prevents photoreceptor death and preserves retinal function in a Bardet-Biedl syndrome mouse model

David L. Simons, Sanford L. Boye, William W. Hauswirth, Samuel M. Wu

Proceedings of the National Academy of Sciences · 2011 · 86 citations · 38 references

DOIFull text

Open access

Concepts

Abstract

Patients with Bardet-Biedl syndrome (BBS) experience severe retinal degeneration as a result of impaired photoreceptor transport processes that are not yet fully understood. To date, there is no effective treatment for BBS-associated retinal degeneration, and blindness is imminent by the second decade of life. Here we report the development of an adeno-associated viral (AAV) vector that rescues rhodopsin mislocalization, maintains nearly normal-appearing rod outer segments, and prevents photoreceptor death in the Bbs4-null mouse model. Analysis of the electroretinogram a-wave indicates that rescued rod cells are functionally indistinguishable from wild-type rods. These results demonstrate that gene therapy can prevent retinal degeneration in a mammalian BBS model.

References

38